Bolt Biotherapeutics shares soar on acquisition news following reverse merger with Prana Therapies

Bolt Biotherapeutics (Nasdaq: BOLT) shares soared on acquisition news, according to a report. The move follows the company's announced reverse merger with Prana Therapies.

Detected & updated continuously · Source: Nebula